Viewing Study NCT03213457


Ignite Creation Date: 2025-12-24 @ 6:44 PM
Ignite Modification Date: 2026-06-14 @ 4:48 PM
Study NCT ID: NCT03213457
Status: COMPLETED
Last Update Posted: 2024-12-20
First Post: 2017-07-07
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A Clinical Study to Evaluate the Safety and Efficacy of Elagolix in Participants With Moderate to Severe Endometriosis-Associated Pain
Sponsor: AbbVie
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Endometriosis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Elagolix View
None Endometriosis associated pain View
None Dysmenorrhea (DYS) View
None Non-menstrual pelvic pain (NMPP) View
None ORILISSA View